Effects of a herbal gel containing carvacrol and chalcones on alveolar bone resorption in rats on experimental periodontitis.
Carvacrol and dimeric chalcones are the respective bioactive components of Lippia sidoides and Myracrodruon urundeuva, popular medicinal plants of Northeastern Brazil with proven antimicrobial and antiinflammatory properties. Periodontal disease is associated with inflammation and microbiological proliferation, thus the study aimed to investigate the effect of a topical gel based on carvacrol and chalcones in the experimental periodontal disease (EPD) in rats. Animals were treated with carvacrol and/or chalcones gel, immediately after EPD induction, three times a day for 11 days. Appropriate controls were included in the study. Animals were weighed daily. They were killed on day 11, the mandibles dissected and alveolar bone loss was measured. The periodontium were examined at histopathology and the neutrophil influx into the gingiva was assayed using myeloperoxidase activity. The bacterial flora were assessed through culture of the gingival tissue. Alveolar bone loss was significantly (p < 0.05) inhibited by combined carvacrol and chalcones gel, compared with the vehicle and non-treated groups. The treatment with the combined gel reduced tissue lesion at histopathology, decreased myeloperoxidase activity in gingival tissue and inhibited the growth of oral microorganisms as well as the weight loss. Carvacrol and chalcones combination gel has a beneficial effect upon EPD in this model.
Botelho
Marco Antonio
MA
Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceará, Brazil. marcobotelho1@gmail.com
Rao
Vietla Satyanarayana
VS
Montenegro
Danusa
D
Bandeira
Mary Anne Menezes
MA
Fonseca
Said Gonçalves Cruz
SG
Nogueira
Nadia Accioly Pinto
NA
Ribeiro
Ronaldo Albuquerque
RA
Brito
Gerly Anne Castro
GA
D016301:Alveolar Bone Loss / Q000188:drug therapy*; D000818:Animals; D001862:Bone Resorption / Q000188:drug therapy*; D047188:Chalcones / Q000494:pharmacology* / Q000627:therapeutic use; D000081007:Cymenes; D005782:Gels; D007249:Inflammation / Q000188:drug therapy; D032411:Lippia / Q000737:chemistry; D008297:Male; D039821:Monoterpenes / Q000494:pharmacology* / Q000627:therapeutic use; D010518:Periodontitis / Q000188:drug therapy*; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar
D047188:Chalcones; D000081007:Cymenes; D005782:Gels; D039821:Monoterpenes; C073316:carvacrol